GT BIOPHARMA INC

CUSIP: 36254L209 Class: COMMON

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 22,867 Value ($000) $6 Avg Close — Range —
Q3 2023
Shares 10,424 Value ($000) $3 Avg Close — Range —
Q2 2023
Shares 10,500 Value ($000) $3 Avg Close — Range —
Q1 2023
Shares 10,507 Value ($000) $6 Avg Close — Range —
Q4 2022
Shares 10,545 Value ($000) $9 Avg Close — Range —
Q3 2022
Shares 25,034 Value ($000) $0 Avg Close — Range —
Q2 2022
Shares 10,652 Value ($000) $0 Avg Close — Range —
Q1 2022
Shares 10,677 Value ($000) $31 Avg Close — Range —
Q4 2021
Shares 71,234 Value ($000) $217 Avg Close — Range —
Q3 2021
Shares 52,426 Value ($000) $353 Avg Close — Range —